Berkshire Hathaway
BRK-B · Multi-Sector Holdings
$542.19
0.9%MetLife
MET · Life & Health Insurance
$98.82
4.6%The short version
- Berkshire Hathaway is the larger business, with $371.4B of revenue in fiscal 2025 against $77.1B for MetLife, about 4.8 times as much.
- MetLife grew revenue faster (8.6%, against 0.0%).
| Latest fiscal year | BRK-B · FY25 | MET · FY25 |
|---|---|---|
| Size | ||
| Market cap | — | $63.9B |
| Revenue | $371.4B | $77.1B |
| Free cash flow | $25.0B | — |
| Net income | $67.0B | $3.4B |
| Growth | ||
| Revenue growth | 0.0% | 8.6% |
| 5-year growth | 8.6% | 2.6% |
| Share count change | — | −5.3% |
| Profitability | ||
| Gross margin | — | — |
| Operating margin | — | 8.0% |
| Net margin | 18.0% | 4.4% |
| FCF margin | 6.7% | — |
| Return on capital | — | — |
| Return on equity | 9.8% | — |
| Balance sheet | ||
| Net debt | — | −$10.8B |
| Net debt / EBITDA | — | −1.7x |
| Dividends and buybacks | $0.0M | $4.4B |
| Valuation & quality | ||
| P/E | — | 18.9x |
| Piotroski F-score | — | — |
FY16
BRK-B $215.1B
MET $60.8B
FY17
BRK-B $239.9B
MET $62.3B
FY18
BRK-B $247.8B
MET $67.9B
FY19
BRK-B $254.6B
MET $69.6B
FY20
BRK-B $245.6B
MET $67.8B
FY21
BRK-B $276.2B
MET $68.7B
FY22
BRK-B $302.0B
MET $68.8B
FY23
BRK-B $364.5B
MET $66.9B
FY24
BRK-B $371.4B
MET $71.0B
FY25
BRK-B $371.4B
MET $77.1B
BRK-B
MET
FY16
BRK-B —
MET —
FY17
BRK-B —
MET —
FY18
BRK-B —
MET —
FY19
BRK-B —
MET —
FY20
BRK-B —
MET —
FY21
BRK-B —
MET —
FY22
BRK-B —
MET 8.7%
FY23
BRK-B —
MET 8.6%
FY24
BRK-B —
MET 8.5%
FY25
BRK-B —
MET 8.0%
BRK-B
MET
FY16
BRK-B $19.7B
MET —
FY17
BRK-B $34.0B
MET —
FY18
BRK-B $22.9B
MET —
FY19
BRK-B $22.7B
MET —
FY20
BRK-B $26.8B
MET —
FY21
BRK-B $26.2B
MET —
FY22
BRK-B $21.9B
MET —
FY23
BRK-B $29.8B
MET —
FY24
BRK-B $11.6B
MET —
FY25
BRK-B $25.0B
MET —
BRK-B
MET
FY16
BRK-B —
MET —
FY17
BRK-B —
MET —
FY18
BRK-B —
MET —
FY19
BRK-B —
MET —
FY20
BRK-B —
MET —
FY21
BRK-B —
MET —
FY22
BRK-B —
MET —
FY23
BRK-B —
MET —
FY24
BRK-B —
MET —
FY25
BRK-B —
MET —
BRK-B
MET
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.